Evidence map›Paper›PMID 24794432›Full record

ArticleCell reports2014

Fate of iPSCs derived from azoospermic and fertile men following xenotransplantation to murine seminiferous tubules.

Cyril Ramathal, Jens Durruthy-Durruthy, Meena Sukhwani, Joy E Arakaki, Paul J Turek, Kyle E Orwig, Renee A Reijo Pera

Registry-linked trialAbstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06841861 (A Study of Therapeutic Spermatogonial Differentiation for Infertile Men Via Testicular Organoid), which is not on this map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06841861 phase1 / phase2recruitingnot on this mapstarted 2024, after this paper: background citation

A Study of Therapeutic Spermatogonial Differentiation for Infertile Men Via Testicular Organoid

TypeinterventionalSponsorCellARTs Inc.Ran2024 to 2027Enrolled100ConditionsInfertility, Male, Gene Abnormality, Sterility, MaleArmsStem cell, Genetic Screening, Genetic Reprogramming, Cell Maturation
3 · Its place in the literature

Who cites it

47 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Perspectives: Methods for Evaluating Primate Spermatogonial Stem Cells.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  11. Review
  12. Article
  13. Review
  14. Transcriptional control of human gametogenesis.Human reproduction update · 2022
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cyril RamathalInstitute for Stem Cell Biology & Regenerative Medicine, Departments of Genetics and Obstetrics and Gynecology, Stanford University, Stanford, CA 94305, USA.
Jens Durruthy-DurruthyInstitute for Stem Cell Biology & Regenerative Medicine, Departments of Genetics and Obstetrics and Gynecology, Stanford University, Stanford, CA 94305, USA.
Meena SukhwaniDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Womens Research Institute, Pittsburgh PA 15213.
Joy E ArakakiInstitute for Stem Cell Biology & Regenerative Medicine, Departments of Genetics and Obstetrics and Gynecology, Stanford University, Stanford, CA 94305, USA.
Paul J TurekThe Turek Clinic, San Francisco, CA 94133, USA.
Kyle E OrwigDepartment of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Womens Research Institute, Pittsburgh PA 15213.
Renee A Reijo PeraInstitute for Stem Cell Biology & Regenerative Medicine, Departments of Genetics and Obstetrics and Gynecology, Stanford University, Stanford, CA 94305, USA. Electronic address: reneer@stanford.edu.

Funding

Basic and Translational Research iPSC-based hematologic and vascular therapiesU01HL100397 · NHLBI · STANFORD UNIVERSITY · PI COOKE, JOHN P · 2009 to 2015
$7.4M
Stanford University Center for Reproductive and Stem Cell biologyU54HD068158 · NICHD · STANFORD UNIVERSITY · PI HSUEH, AARON · 2011 to 2013
$5.0M
Stanford University Center for Reproductive and Stem Cell biologyP50HD068158 · NICHD · STANFORD UNIVERSITY · PI HSUEH, AARON · 2014 to 2015
$3.3M
NHLBI NIH HHS U01 HL100397NHLBI NIH HHS U01HL100397NICHD NIH HHS P50 HD068158NICHD NIH HHS U54 HD068158
6 · The paper itself

Abstract

Historically, spontaneous deletions and insertions have provided means to probe germline developmental genetics in Drosophila, mouse and other species. Here, induced pluripotent stem cell (iPSC) lines were derived from infertile men with deletions that encompass three Y chromosome azoospermia factor (AZF) regions and are associated with production of few or no sperm but normal somatic development. AZF-deleted iPSC lines were compromised in germ cell development in vitro. Undifferentiated iPSCs transplanted directly into murine seminiferous tubules differentiated extensively to germ-cell-like cells (GCLCs) that localized near the basement membrane, demonstrated morphology indistinguishable from fetal germ cells, and expressed germ-cell-specific proteins diagnostic of primordial germ cells. Alternatively, all iPSCs that exited tubules formed primitive tumors. iPSCs with AZF deletions produced significantly fewer GCLCs in vivo with distinct defects in gene expression. Findings indicate that xenotransplantation of human iPSCs directs germ cell differentiation in a manner dependent on donor genetic status.

Indexed as

AnimalsAzoospermiaCell DifferentiationCell LineFertilityHumansInduced Pluripotent Stem CellsMaleMiceMice, NudeSeminiferous TubulesSkinTransplantation, Heterologous

Identifiers

PMID24794432
PMCPMC4283769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.